The Food and Drug Administration has joined media in mocking users of ivermectin, but the antiviral drug is featured on the National Institutes of Health website as a treatment for COVID-19.
Ivermectin is the second drug listed - under the highly touted, expensive COVID-19 drug with many side effects, remdesivir - on an NIH page titled "Antiviral Agents That Are Approved or Under Evaluation for the Treatment of COVID-19.".
Ivermectin has not been approved as a COVID-19 treatment.
Merck, the producer of ivermectin, applied earlier this month for emergency use authorization for a new COVID-19 treatment called molnupirivar.
The NIH said unspecified "Neurological" adverse effects have been seen in the treatment of parasitic disease, but it's unclear if they are connected to the drug or to the underlying conditions.
Dr. Bryan Ardis recently drew attention to ivermectin's status on the NIH website in an interview on the Canadian podcast "Live with Laura-Lynn.".
In September, more than 8,600 scientists and physicians from around the world signed a declaration condemning public policy makers of "Crimes against humanity" for restricting life-saving treatments such as ivermectin and hydroxychloroquine while quashing debate and scientific inquiry.
Wednesday, October 20, 2021
NIH website features much-maligned ivermectin as COVID treatment
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment